N-[3-(4-methyl-piperazin-1-yl)-propyl]-benzene-1,2-diamine | 62552-57-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-[3-(4-methyl-piperazin-1-yl)-propyl]-benzene-1,2-diamine
• 英文别名: N-[3-(4-methyl-1-piperazinyl)propyl]-o-phenylenediamine；3-(4-Methyl-1-piperazinyl)propyl-o-phenylenediamine；2-N-[3-(4-methylpiperazin-1-yl)propyl]benzene-1,2-diamine
• CAS: 62552-57-2
• 化学式: C₁₄H₂₄N₄
• 分子量: 248.371
• InChiKey: WRYRPEVFTAIIDT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  44.5
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[3-(4-methyl-piperazin-1-yl)-propyl]-benzene-1,2-diamine 以 乙醇 为溶剂， 以57%的产率得到3,4-dichloro-N-{1-[3-(4-methyl-piperazin-1-yl)-propyl]-1H-benzoimidazol-2-yl}-benzamide
  参考文献：
  名称：

  Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles

  摘要：

  1-[3-(二烷基氨基)丙基]-2-酰胺基苯并咪唑和2-酰胺基氨基-3-[3-(二烷基氨基)丙基]咪唑并[4,5-b]吡啶以及它们与药用可接受的酸盐，是一类新型化合物，在治疗炎症性疾病中有用。提供了替代制备方法，并详细描述了主要的合成途径。

  公开号：

  US04002623A1
• 作为产物：
  描述：

  1-(3-氨丙基)-4-甲基哌嗪 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 24.0h， 生成 N-[3-(4-methyl-piperazin-1-yl)-propyl]-benzene-1,2-diamine
  参考文献：
  名称：

  Alamanni; Pirisino; Savelli, Farmaco, Edizione Scientifica, 1981, vol. 36, # 5, p. 359 - 371

  摘要：

  DOI：

文献信息

• Medicaments
  申请人：Alberti John Michael

  公开号：US20050153978A1

  公开（公告）日：2005-07-14

  A method of treating an Msk-1 and/or ROCK(1 and 2) mediated disease or condition in a mammal comprising administration of an effective amount of a compounds of the formula (I) and physiologically acceptable salts thereof wherein, R 1 is a 5, or 6 membered heterocyclic group selected from group a, b, c or d wherein X 1 is a group selected from N or CR 7 and X 2 is a group selected from O, S or NR 8 ; X 3 and X 4 which may be the same or different is a group selected from N or CR 7 ; X 5 is a group selected from O, S or NR 8 and X 6 is N or CR 7 ; X 7 , X 8 and X 9 may be the same or different and selected from a group N or CR 7 , pharmaceutical compositions, novel compounds and processes for their preparation.

  一种治疗哺乳动物中MSK-1和/或ROCK（1和2）介导的疾病或病况的方法，包括给予化合物(I)及其生理上可接受的盐的有效量，其中，R1是从a、b、c或d组中选择的5个或6个成员的杂环基团，其中X1是选择自N或CR7的基团，X2是选择自O、S或NR8的基团；X3和X4可以相同或不同，是选择自N或CR7的基团；X5是选择自O、S或NR8的基团，X6是N或CR7；X7、X8和X9可以相同或不同，选择自N或CR7的基团；制备这些新化合物的药物组合物和方法。
• 2-Acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines
  申请人：Pfizer

  公开号：US04059584A1

  公开（公告）日：1977-11-22

  1-[3-(Dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)propyl]imidazo[4,5-b]pyridines and salts thereof with pharmaceutically acceptable acids, a novel class of compounds useful in the treatment of inflammatory conditions. Alternate methods of preparation are provided and the primary synthetic route is described in detail.

  1-[3-(二烷基氨基)丙基]-2-酰胺基苯并咪唑和2-酰胺基-3-[3-(二烷基氨基)丙基]咪唑[4,5-b]吡啶及其与药学上可接受的酸盐是一种新的化合物类别，可用于治疗炎症疾病。提供了替代制备方法，并详细描述了主要的合成路线。
• Parallel synthesis of a series of potentially brain penetrant aminoalkyl benzoimidazoles
  作者：Iolanda Micco、Arianna Nencini、Joanna Quinn、Hendrick Bothmann、Chiara Ghiron、Alessandro Padova、Silvia Papini

  DOI：10.1016/j.bmc.2007.11.068

  日期：2008.3

  Alpha7 agonists were identified via GOLD (CCDC) docking in the putative agonist binding site of an alpha7 homology model and a series of aminoalkyl benzoimidazoles was synthesised to obtain potentially brain penetrant drugs. The array was prepared starting from the reaction of ortho-fluoronitrobenzenes with a selection of diamines, followed by reduction of the nitro group to obtain a series of monoalkylated phenylene diamines. N,N'-Carbonyidiimidazole (CDI) mediated acylation, followed by a parallel automated work-up procedure, afforded the monoacylated phenylenediamines which were cyclised under acidic conditions. Parallel work-up and purification afforded the array products in good yields and purities with a robust parallel methodology which will be useful for other libraries. Screening for alpha7 activity revealed compounds with agonist activity for the receptor. (C) 2007 Elsevier Ltd. All rights reserved.
• Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors
  作者：Bing-Lei Yao、Yan-Wen Mai、Shuo-Bin Chen、Hua-Ting Xie、Pei-Fen Yao、Tian-Miao Ou、Jia-Heng Tan、Hong-Gen Wang、Ding Li、Shi-Liang Huang、Lian-Quan Gu、Zhi-Shu Huang

  DOI：10.1016/j.ejmech.2015.01.024

  日期：2015.3

  A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II. (C) 2015 Elsevier Masson SAS. All rights reserved.
• Savelli; Boido; Mule, Il Farmaco, 1989, vol. 44, # 2, p. 125 - 140
  作者：Savelli、Boido、Mule、Piu、Alamanni、Pirisino、Satta、Peana

  DOI：——

  日期：——